Articles

Barriers and triumphs of an underserved patient group. It is undeniable that clinical trials for rare diseases are more challenging to design and execute. Unlike trials with more frequently occurring diseases, rare disease trials have a smaller number of eligible...

In today’s digital, on-demand world, success means creating new rules of patient engagement that shifts from a single source of truth to personalized, real-time multi-channel interactions. While pharma companies have realized the importance of developing multichannel strategies, many are just...

BHS-Sonthofen offers a modular pilot plant for solid-liquid separation Instability on markets and greater frequency of product changes are two of several trends that promote the demand for flexible systems in the fine chemical and pharmaceutical industries. Modular production systems...

Capsule-based dry powder inhalers are making treating conditions of the lung, safe, effective and patient-centered Between 1990 and 2017, Chronic Obstructive Pulmonary Disease (COPD) was the second highest cause of death in India according to University of Washington’s Global Burden...

When biopharmaceutical companies launch a new product, they all too often pursue new releases with no clear end in mind for vital product features like secondary packaging and device assembly. Even commercially minded teams frequently give their secondary packaging...

The COVID-19 pandemic has seen billions of people experience some form of ‘stay at home’, and for many, daily life has changed enormously. Now, even as we consider a slow return to ‘normal’, questions are raised over whether going...

As the COVID-19 pandemic continues to spread across the world, clinicians, academic institutions, private organizations, and governments are working tirelessly to find treatments to help patients and at-risk populations threatened by this novel disease. The best minds in infectious...